You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 8, 2024

XTORO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Xtoro patents expire, and what generic alternatives are available?

Xtoro is a drug marketed by Fonseca Biosciences and is included in one NDA. There are four patents protecting this drug.

This drug has forty-two patent family members in eighteen countries.

The generic ingredient in XTORO is finafloxacin. Additional details are available on the finafloxacin profile page.

DrugPatentWatch® Generic Entry Outlook for Xtoro

Xtoro was eligible for patent challenges on December 17, 2018.

By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be July 2, 2030. This may change due to patent challenges or generic licensing.

Indicators of Generic Entry

< Available with Subscription >

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for XTORO?
  • What are the global sales for XTORO?
  • What is Average Wholesale Price for XTORO?
Summary for XTORO
International Patents:42
US Patents:4
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 44
Patent Applications: 73
DailyMed Link:XTORO at DailyMed
Drug patent expirations by year for XTORO
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for XTORO
Generic Entry Date for XTORO*:
Constraining patent/regulatory exclusivity:
NDA:
Dosage:
SUSPENSION/DROPS;OTIC

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for XTORO

XTORO is protected by four US patents.

Based on analysis by DrugPatentWatch, the earliest date for a generic version of XTORO is ⤷  Sign Up.

This potential generic entry date is based on patent ⤷  Sign Up.

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

Patents protecting XTORO

Methods for treating ophthalmic, otic, or nasal infections
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE OTITIS EXTERNA

Methods for treating otic infections
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE OTITIS EXTERNA

Finafloxacin suspension compositions
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF ACUTE OTITIS EXTERNA

Compositions and methods for treating ophthalmic, octic, or nasal infections
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Fonseca Biosciences XTORO finafloxacin SUSPENSION/DROPS;OTIC 206307-001 Dec 17, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for XTORO

When does loss-of-exclusivity occur for XTORO?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 7372
Patent: COMPOSICIONES Y METODOS PARA TRATAR INFECCIONES OFTALMICAS OTICAS O NASALES
Estimated Expiration: ⤷  Sign Up

Australia

Patent: 10266120
Patent: Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
Estimated Expiration: ⤷  Sign Up

Brazil

Patent: 1016257
Patent: composições compreendendo finafloxacino e métodos para tratar infecções oftálmicas, ópticas ou nasais
Estimated Expiration: ⤷  Sign Up

Canada

Patent: 65852
Patent: COMPOSITIONS COMPRENANT DE LA FINAFLOXACINE ET METHODES DE TRAITEMENT D'INFECTIONS OPHTALMIQUES, OTIQUES OU NASALES (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS)
Estimated Expiration: ⤷  Sign Up

Chile

Patent: 11003327
Patent: Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
Estimated Expiration: ⤷  Sign Up

China

Patent: 2470139
Patent: Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
Estimated Expiration: ⤷  Sign Up

Patent: 5687111
Patent: 用于治疗眼、耳或鼻感染的包含非那沙星的组合物和方法 (Compositions and methods for treating ophthalmic, otic, or nasal infections)
Estimated Expiration: ⤷  Sign Up

European Patent Office

Patent: 48587
Patent: COMPOSITIONS COMPRENANT DE LA FINAFLOXACINE ET MÉTHODES DE TRAITEMENT D'INFECTIONS OPHTALMIQUES, OTIQUES OU NASALES (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS)
Estimated Expiration: ⤷  Sign Up

Japan

Patent: 84012
Estimated Expiration: ⤷  Sign Up

Patent: 12532115
Estimated Expiration: ⤷  Sign Up

Patent: 15134827
Patent: 眼、耳または鼻の感染症を処置するためのフィナフロキサシンを含む組成物および方法 (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS)
Estimated Expiration: ⤷  Sign Up

Mexico

Patent: 12000136
Patent: COMPOSICIONES QUE COMPRENDEN FINAFLOXACINA Y METODOS PARA TRATAR INFECCIONES OFTALMICAS, OTICAS, O NASALES. (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS.)
Estimated Expiration: ⤷  Sign Up

Russian Federation

Patent: 70731
Patent: КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ФИНАФЛОКСАЦИИ, И СПОСОБЫ ЛЕЧЕНИЯ ОФТАЛЬМОЛОГИЧЕСКИХ, УШНЫХ ИЛИ НАЗАЛЬНЫХ ИНФЕКЦИЙ (FINAFLOXACIN-INCLUDING COMPOSITIONS, AND METHODS OF TREATING OPHTHALMOLOGICAL, AURAL AND NASAL INFECTIONS)
Estimated Expiration: ⤷  Sign Up

Patent: 12103458
Patent: КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ФИНАФЛОКСАЦИИ, И СПОСОБЫ ЛЕЧЕНИЯ ОФТАЛЬМОЛОГИЧЕСКИХ, УШНЫХ ИЛИ НАЗАЛЬНЫХ ИНФЕКЦИЙ
Estimated Expiration: ⤷  Sign Up

South Africa

Patent: 1109492
Patent: COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC,OTIC,OR NASAL INFECTIONS
Estimated Expiration: ⤷  Sign Up

South Korea

Patent: 1541823
Estimated Expiration: ⤷  Sign Up

Patent: 120114211
Patent: COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS
Estimated Expiration: ⤷  Sign Up

Spain

Patent: 94775
Estimated Expiration: ⤷  Sign Up

Taiwan

Patent: 60181
Estimated Expiration: ⤷  Sign Up

Patent: 1102395
Patent: Compositions and methods for treating ophthalmic, otic, or nasal infections
Estimated Expiration: ⤷  Sign Up

Uruguay

Patent: 758
Patent: COMPOSICIONES Y MÉTODOS PARA EL TRATAMIENTO DE INFECCIONES ÓPTICAS, NASALES U OFTÁLMICAS
Estimated Expiration: ⤷  Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering XTORO around the world.

Country Patent Number Title Estimated Expiration
Russian Federation 2693476 КОМПОЗИЦИИ ФИНАФЛОКСАЦИНА В ВИДЕ СУСПЕНЗИИ (FINAFLOXACIN SUSPENSION COMPOSITIONS) ⤷  Sign Up
European Patent Office 2448587 COMPOSITIONS COMPRENANT DE LA FINAFLOXACINE ET MÉTHODES DE TRAITEMENT D'INFECTIONS OPHTALMIQUES, OTIQUES OU NASALES (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS) ⤷  Sign Up
China 105687111 用于治疗眼、耳或鼻感染的包含非那沙星的组合物和方法 (Compositions and methods for treating ophthalmic, otic, or nasal infections) ⤷  Sign Up
China 102470139 Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections ⤷  Sign Up
Mexico 2012000136 COMPOSICIONES QUE COMPRENDEN FINAFLOXACINA Y METODOS PARA TRATAR INFECCIONES OFTALMICAS, OTICAS, O NASALES. (COMPOSITIONS COMPRISING FINAFLOXACIN AND METHODS FOR TREATING OPHTHALMIC, OTIC, OR NASAL INFECTIONS.) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.